Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2018-01-17 Capital/Financing Update
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Phosphagenics Placement Cleansing Notice 2 pages 246.9KB
Capital/Financing Update Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 regarding the issue of placement shares by Phosphagenics Limited. It details the issuance of new shares under a placement to sophisticated investors, including the number of shares, issue price, and compliance statements. There is no financial report, earnings data, or management discussion. The document is an announcement about a capital raising event (placement of shares). This fits the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is CAP with high confidence.
2018-01-17 English
Appendix 3B 9 pages 428.6KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and references ASX rules related to new securities issuance and quotation. It details the class and number of securities issued, issue price, purpose of the issue, and other related information about the placement of shares. The document is a formal announcement of a new share issue and application for quotation of additional securities on the ASX. It does not contain financial statements, management discussion, or audit information. It is not a report but an announcement of a capital raising event and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is over 11,000 characters, indicating it is a full announcement rather than a brief notice or report publication announcement.
2018-01-17 English
Phosphagenics Placement Secures A$1.37 million 2 pages 248.8KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from Phosphagenics Limited regarding the successful completion of a placement of ordinary shares raising approximately A$1.37 million. It details the placement terms, references the prior entitlement offer, and provides company background and risk disclosures. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is relatively short (3990 characters) and serves as an update on capital raising activity rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2018-01-17 English
Phosphagenics Receipt of R&D Tax Incentive 1 page 2
Regulatory Filings Classification · 95% confidence The document is a short announcement from Phosphagenics Limited regarding the receipt of an R&D Tax Incentive refund for the 2016-17 tax year. It does not contain any financial statements, detailed financial performance data, or comprehensive report content. The length is only 1672 characters, which is quite short and typical of a regulatory or market announcement. There is no indication that this is an annual report, earnings release, or any detailed financial or management report. It is an update on a specific financial event (receipt of a tax refund), which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2018-01-16 English
Ceasing to be a substantial holder 4 pages 145.9KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001 Section 671B. It details changes in relevant interests of a substantial shareholder, Allan Gray Australia Pty Ltd, including tables of related bodies corporate, funds managed, and changes in shareholdings. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2018-01-04 English
Phosphagenics Announces Results of Dairy Trial 2 pages 252.8KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing the results of a specific scientific trial conducted by Phosphagenics Limited regarding their TPM® product in dairy cattle. It discusses the trial outcomes, scientific observations, and future plans but does not contain financial statements, regulatory certifications, or detailed financial data. It is not an annual or interim report, earnings release, or any form of regulatory filing. The content is focused on trial results and company commentary rather than financial or governance disclosures. Therefore, it fits best as a general regulatory announcement or market announcement rather than a formal financial or governance report. Given the nature and length of the document, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2017-12-21 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.